Home > Riviste > Minerva Anestesiologica > Fascicoli precedenti > Minerva Anestesiologica 2018 February;84(2) > Minerva Anestesiologica 2018 February;84(2):204-15



Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca


Publication history
Per citare questo articolo


REVIEW   Freefree

Minerva Anestesiologica 2018 February;84(2):204-15

DOI: 10.23736/S0375-9393.17.12130-9


lingua: Inglese

How to optimize the lung donor

Gabriele SALES 1, Andrea COSTAMAGNA 1, Vito FANELLI 1, Massimo BOFFINI 1, Francesco PUGLIESE 2, Luciana MASCIA 3, Luca BRAZZI 1

1 Department of Surgical Sciences, University of Turin, Turin, Italy; 2 Paride Stefanini Department of General and Specialty Surgery, Sapienza University of Rome, Rome, Italy; 3 Department of Biotechnological and Medical and Surgical Sciences, Sapienza University of Rome, Rome, Italy


Over the last two decades, lung transplantation emerged as the standard of care for patients with advanced and terminal lung disease. Despite the increment in lung transplantation rates, in 2016 the overall mortality while on waiting list in Italy reached 10%, whereas only 39% of the wait-list patients were successfully transplanted. A number of approaches, including protective ventilatory strategy, accurate management of fluid balance, and administration of a hormonal resuscitation therapy, have been reported to improve lung donor performance before organ retrieval. These approaches, in conjunction with the use of ex-vivo lung perfusion technique contributed to expand the lung donor pool, without affecting the harvest of other organs and the outcomes of lung recipients. However, the efficacy of issues related to the ex-vivo lung perfusion technique, such as the optimal ventilation strategy, the ischemia-reperfusion induced lung injury management, the prophylaxis of germs transmission from donor to recipient and the application of targeted pharmacologic therapies to treat specific donor lung injuries are still to be explored. The main objective of the present review is to summarize the “state-of-art” strategies to optimize the donor lungs and to present the actual role of ex-vivo lung perfusion in the process of lung transplant. Moreover, different approaches about the technique reported in literature and several issues that are under investigation to treat specific donor lung injury will be discussed.

KEY WORDS: Lung transplantation - Organ preservation - Lung injury - Donor selection

inizio pagina